AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Tekna Holding ASA

Regulatory Filings Nov 22, 2023

3772_rns_2023-11-22_3f194255-dcbe-49b3-a05e-c7aa2c6e45e4.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

TEKNA Receives Order for CAD 1.5 million of Titanium Powder

TEKNA Receives Order for CAD 1.5 million of Titanium Powder

22.11.2023 09:00:01 CET | Tekna Holding ASA | Non-regulatory press releases

ARENDAL, NO / SHERBROOKE, QC. 22 November 2023 - Tekna (OSE: TEKNA), a

world-leading provider of advanced materials solutions to industry, is pleased

to announce another significant order valued at CAD 1.5 million for titanium

powder for medical applications.

The contract is for Tekna's main size titanium alloy powder exclusively used for

medical applications and is scheduled for delivery within the first three

quarters of 2024. This represents a notable 60% increase in orders from this

customer compared to the previous year and forms part of a three-year

distribution agreement. The customer is a leading distributor of titanium

powder, holding a significant position in the medical and dental industry across

Europe and worldwide. This partnership not only broadens Tekna's presence but

also enhances its influence in a global market.

"This substantial order is a testament to Tekna's growing influence and

reputation in the advanced materials industry, particularly in the medical

sector, which has grown to become one of the most advanced and prominent users

of additive manufacturing on a global scale. Partnering with a key player in the

European market not only strengthens our position but also highlights the trust

and reliability associated with our products. We are proud to play a pivotal

role in advancing medical technologies through our specialized titanium powders

," said Luc Dionne, CEO of Tekna.

This contract underscores Tekna's commitment to excellence and innovation in the

field of advanced materials and their dedication to meeting the increasing

demands of the medical sector. With this new agreement, Tekna continues to

solidify its position as a key supplier of specialized materials on a global

scale. Tekna's quality management system is ISO 13485:2016 certified for medical

applications.

DISCLOSURE REGULATION

This information is subject to the disclosure requirements pursuant to Section

5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Arina Van Oost, Investor Relations | VP Corporate Strategic Development &

Innovation, Tekna Holding ASA, +14388856330, +33670115190,

[email protected]

ABOUT TEKNA HOLDING ASA

Tekna is a world-leading provider of advanced materials to industry,

headquartered in Sherbrooke, Canada.

Tekna produces high-purity metal powders for applications such as 3D printing in

the aerospace, medical and automotive sectors, as well as optimized induction

plasma systems for industrial research and production. With its unique,

IP-protected plasma technology, the company is well positioned in the growing

market for advanced nanomaterials within the electronics and batteries

industries.

Building on 30 years of delivering excellence, Tekna is a global player

recognized for its quality products and its commitment to its large base of

multinational blue-chip customers. Tekna's powder products increase productivity

and enable more efficient use of materials, thereby paving the way towards a

more resilient supply chain and circular economy.

https://www.tekna.com

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847682/2761/3864/Download%20announcement

%20as%20PDF.pdf

Talk to a Data Expert

Have a question? We'll get back to you promptly.